Tevogen Bio (TVGN) Institutional Ownership $1.18 +0.02 (+1.72%) Closing price 04:00 PM EasternExtended Trading$1.17 -0.01 (-0.51%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Tevogen Bio (NASDAQ:TVGN)Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$428.58KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$175.66K Get TVGN Insider Trade Alerts Want to know when executives and insiders are buying or selling Tevogen Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TVGN Institutional Buying and Selling by Quarter Tevogen Bio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2025 Goldman Sachs Group Inc.54,761$59K0.0%-29.9%0.030% 5/12/2025 Nuveen LLC90,253$97K0.0%N/A0.049% 2/14/2025 Northern Trust Corp118,415$122K0.0%+13.0%0.068% 2/13/2025 XTX Topco Ltd53,858$55K0.0%N/A0.031% 2/13/2025 Barclays PLC45,600$48K0.0%+39.2%0.026% 2/12/2025 Geode Capital Management LLC451,851$465K0.0%+31.2%0.258% 2/12/2025 JPMorgan Chase & Co.39,207$40K0.0%+74.2%0.022% 1/24/2025 China Universal Asset Management Co. Ltd.37,117$38K0.0%N/A0.021% 11/15/2024 Polar Asset Management Partners Inc.1,577,387$581K0.0%-20.6%0.924% 11/15/2024 HGC Investment Management Inc.223,077$82K0.0%N/A0.131% 5/9/2024 Portland Global Advisors LLC5,782,209$21.68M3.0%N/A36.550% (Data available from 1/1/2016 forward) TVGN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TVGN shares? During the previous two years, 11 institutional investors and hedge funds held shares of Tevogen Bio. The most heavily invested institutionals were Portland Global Advisors LLC ($21.68M), Polar Asset Management Partners Inc. ($581K), Geode Capital Management LLC ($465K), Northern Trust Corp ($122K), Nuveen LLC ($97K), HGC Investment Management Inc. ($82K), and Goldman Sachs Group Inc. ($59K).Learn more on TVGN's institutional investors. Which institutional investors have been buying Tevogen Bio stock? Of the 9 institutional investors that purchased Tevogen Bio stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Portland Global Advisors LLC ($5.78M), HGC Investment Management Inc. ($223.08K), Geode Capital Management LLC ($107.57K), Nuveen LLC ($90.25K), XTX Topco Ltd ($53.86K), China Universal Asset Management Co. Ltd. ($37.12K), and JPMorgan Chase & Co. ($16.70K). How much institutional buying is happening at Tevogen Bio? Institutional investors have bought a total of 6,337,217 shares in the last 24 months. This purchase volume represents approximately $22.11M in transactions. Which Tevogen Bio major shareholders have been selling company stock? The following institutional investors have sold Tevogen Bio stock in the last 24 months: Polar Asset Management Partners Inc. ($408.23K), and Goldman Sachs Group Inc. ($23.40K). How much institutional selling is happening at Tevogen Bio? Institutional investors have sold a total of 431,624 shares in the last 24 months. This volume of shares sold represents approximately $175.66K in transactions. Related Companies Ardelyx Institutional Ownership Zymeworks Institutional Ownership LENZ Therapeutics Institutional Ownership CureVac Institutional Ownership CorMedix Institutional Ownership Chimerix Institutional Ownership Avid Bioservices Institutional Ownership Cronos Group Institutional Ownership Praxis Precision Medicines Institutional Ownership Nurix Therapeutics Institutional Ownership This page (NASDAQ:TVGN) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tevogen Bio Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tevogen Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.